DprE1-IN-10, with the CAS number 1254782-81-4, is a small molecule inhibitor specifically targeting the enzyme DprE1 (Decaprenylphosphoryl-β-D-ribose 2'-oxidase), which plays a crucial role in the biosynthesis of mycobacterial cell walls. This compound is of particular interest in the field of medicinal chemistry and drug development, especially for its potential application against Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. DprE1-IN-10 exhibits characteristics typical of enzyme inhibitors, including the ability to bind selectively to the active site of DprE1, thereby disrupting its function and inhibiting the growth of the bacteria. The compound's efficacy, selectivity, and pharmacokinetic properties are essential for its development as a therapeutic agent. Additionally, research into DprE1-IN-10 may involve studying its solubility, stability, and interaction with biological systems to assess its potential as a viable drug candidate. Overall, DprE1-IN-10 represents a promising avenue for combating drug-resistant strains of tuberculosis.

DprE1-IN-10

1254782-81-4: DprE1-IN-10, with the CAS number 1254782-81-4, is a small molecule inhibitor specifically targeting the enzyme DprE1 (Decaprenylphosphoryl-β-D-ribose 2'-oxidase), which plays a crucial role in the biosynthesis of mycobacterial cell walls. This compound is of particular interest in the field of medicinal chemistry and drug development, especially for its potential application against Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. DprE1-IN-10 exhibits characteristics typical of enzyme inhibitors, including the ability to bind selectively to the active site of DprE1, thereby disrupting its function and inhibiting the growth of the bacteria. The compound's efficacy, selectivity, and pharmacokinetic properties are essential for its development as a therapeutic agent. Additionally, research into DprE1-IN-10 may involve studying its solubility, stability, and interaction with biological systems to assess its potential as a viable drug candidate. Overall, DprE1-IN-10 represents a promising avenue for combating drug-resistant strains of tuberculosis.

<p>DprE1-IN-10 (hit 2), an inhibitor of Decaprenylphosphoryl-β-D-ribose-2′-epimerase (DprE1), holds potential for the study of tuberculosis.</p>

CAS 1254782-81-4

DprE1-IN-10

DprE1-IN-10

Ref: TM-T88292